Los Serafines Guerrenses Inc Bronx, NY - 10463

Los Serafines Guerrenses Inc is categorized under Temporary Medical Services in Bronx, NY and active since 2008.

Los Serafines Guerrenses Inc was established in 2008, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Temporary Medical Services business, which does work in the B2B market, and is classified as a Temporary Medical Services, under code number 561320 by the NAICS.

If you are seeking more information, feel free to contact Beatriz A Rodriguez at the company’s single location by writing to 3860 Bailey Avenue, Bronx, New York NY 10463 or by phoning (347) 920-5757. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Los Serafines Guerrenses Inc
Contact Person: Beatriz A Rodriguez
Address: 3860 Bailey Avenue, Bronx, New York 10463
Phone Number: (347) 920-5757
Annual Revenue (USD): $100.000 to $499.999
Founded: 2008
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Temporary Medical Services
SIC Code: 7363
NAICS Code: 561320
Share This Business:

Los Serafines Guerrenses Inc was started in 2008 to provide professional Temporary Medical Services under the SIC code 7363 and NAICS code 561320. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Beatriz A Rodriguez for inquiries that concern Los Serafines Guerrenses Inc by calling the company number (347) 920-5757, as your correspondence is most welcome. Additionally, the physical location of the single location of Los Serafines Guerrenses Inc can be found at the coordinates 40.884894,-73.896519 as well as the street address 3860 Bailey Avenue in Bronx, New York 10463.

For its online presence, you may visit Los Serafines Guerrenses Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.